How to Choose a Reliable Stem Cell Supplier?
Choosing a reliable stem cell supplier takes more than comparing prices or reading polished product pages. Cell type, intended use, and local regulatory requirements all matter. Some searches use the phrase “staminal cells,” but that wording alone does not identify a specific cell product. Ask suppliers to state exactly what they provide and how it is characterized.
Look for clear, verifiable records. These may include batch-specific certificates, identity and purity testing, sterility results, storage conditions, and shipping procedures. A label and a certificate are not enough. Check whether documents name the tested batch, explain the methods, and come from qualified laboratories. Ask how the supplier tracks materials from source to delivery, handles deviations, and responds to quality complaints. A dependable supplier should answer plainly and provide evidence without promising guaranteed outcomes.
There is no single document that proves every claim. Compare records, request references where appropriate, and have a qualified scientific or clinical professional review technical details before making a decision. Details matter. A low price may hide gaps in testing, while impressive language may hide little evidence. Even a careful review cannot remove every uncertainty, and that deserves honest attention. This guide outlines practical questions for assessing supplier transparency, quality systems, documentation, and responsible communication. It is educational, not medical advice or an endorsement of any provider.
Define Stem Cell Type, Source, and Intended Use Before Comparing Suppliers
Before comparing suppliers, define the exact cell type you need. “Stem cells” is too broad for a useful quote. Specify, for example, mesenchymal stromal cells or hematopoietic stem cells, along with species and tissue source. Bone marrow, cord tissue, and adipose-derived cells are not interchangeable. Small distinctions matter.
Record the intended use, too. Research-grade cells may not be suitable for clinical work. State whether the cells are for a specific laboratory assay, method development, or another defined purpose. Then ask suppliers for documentation that matches that use, such as cell identity, passage number, viability data, sterility testing, donor-screening information, and lot traceability. Check the details, not just the certificate title. A polished document can still leave questions.
Source affects handling and interpretation. Ask how the material is collected, processed, stored, and shipped. A cryovial arriving warm, or a missing passage number, can complicate an experiment. Confirm expected delivery conditions and what records accompany each lot. For any proposed human use, verify the supplier’s scope and relevant documentation with your institution’s qualified compliance staff. This part can feel tedious. It is worth doing before comparing prices, because a lower quote means little if the cells do not fit the study.
How to Choose a Reliable Stem Cell Supplier
Define the cell type, source, and intended use before comparing suppliers.
Potency levels are ordinal biology categories, not supplier quality scores: pluripotent cells can form cell types from all three germ layers, while multipotent cells can form a more limited range of related cell types. First confirm that the cell type and source suit your intended use; then compare supplier documentation for identity, provenance, passage history, and applicable quality and safety testing.
Verify FDA HCT/P Registration and Donor Screening Under 21 CFR 1271
A reliable stem cell supplier should be able to explain how its products fit FDA regulations. Under 21 CFR Part 1271, certain establishments that manufacture human cells, tissues, and cellular or tissue-based products must register and list their products with the FDA. Check the supplier’s current registration details and ask whether the specific product is listed, where applicable. A registry entry is a starting point, not a seal of approval. Registration does not mean the FDA has approved or endorsed a product.
Donor eligibility deserves equally careful attention. Part 1271 requires applicable donor screening and testing for relevant communicable disease risks. Ask for documentation describing the screening process, tests used, and how donor records are maintained. Clear answers matter. If a supplier cannot explain these steps in plain language, pause and seek clarification. I would not rely on a certificate alone; documents should match the product and its intended handling. Check that identifiers and dates are consistent across records. Small discrepancies can be easy to overlook. Requirements can vary by product type and circumstances, so verify the applicable rules with a qualified regulatory professional before making a decision.
Check MSC Identity Against ISCT Criteria: ≥95% CD73, CD90, and CD105
When choosing a reliable stem cell supplier, ask for lot-specific identity data, not a generic product sheet. ISCT’s widely cited minimal criteria require at least 95% of cells to express CD73, CD90, and CD105 (Dominici et al., Cytotherapy, 2006). Request the flow-cytometry report showing each marker’s positive percentage, the gating strategy, and the controls used. A clear report should identify the tested passage and include viability results.
Numbers can mislead.
The 95% threshold supports identity assessment, but it does not prove potency or predict performance in every application. ISCT also specifies low expression of key hematopoietic markers, including CD45 and CD34, and requires plastic adherence and in-vitro differentiation into three lineages. Ask whether those criteria were assessed and whether the data match the supplied lot. Inspect the plots, not just the certificate. A crowded histogram or unclear gate deserves a follow-up question. These checks take time, and paperwork can still leave gaps.
Not a guarantee.
Treat marker data as one part of supplier qualification, alongside documented culture conditions, contamination testing, and traceable batch records.
Assess Biobanking Controls Against ISO 20387 and Review Batch Records
How to Choose a Reliable Stem Cell Supplier?
Assess Biobanking Controls Against ISO 20387 and Review Batch Records
ISO 20387:2018 sets requirements for biobank competence, consistent operations, and sample traceability. The NCI’s 2016 Best Practices for Biospecimen Resources also stresses documenting collection, processing, storage, and distribution. Ask how each step is recorded. Numbers matter. Compare three consecutive batches, not one polished certificate. Look for donor or source identifiers, passage number, cryopreservation date, storage conditions, and release results. A missing timestamp can make a clean-looking record hard to verify.
Check the freezer. Request temperature logs and deviation reports, including actions taken after an alarm. ISBER’s 2023 Best Practices describe monitoring storage equipment and documenting excursions; ask the supplier to show these records, not just describe procedures. Review batch-specific identity, viability, sterility, and mycoplasma results, with methods and acceptance criteria stated. Compare reported viability with your own thaw-and-count test. Small differences can reflect handling, but unexplained variation across lots deserves questions. That gap matters. ISO alignment is useful evidence, not a guarantee that every vial will perform identically in your assay. Ask for raw, dated records and note any missing details; I would not treat a tidy summary sheet as proof of control.
Compare Post-Thaw Viability, Recovery, and Potency Data Across Lots
A reliable stem cell supplier should provide post-thaw data for several lots, not just a polished result from one batch. Ask for viable cell percentage, total cell recovery, and the assay used to measure each value. Check whether testing followed the recommended thaw and handling protocol. Small changes in timing or dilution can affect results.
Numbers need context. A viability figure describes the cells counted as alive; it does not show how many cells were recovered or whether they retain their intended function. Compare recovery as well as viability, using clearly stated starting and final cell counts. Then review potency data from a relevant, validated assay. Look for results across multiple lots, including the range and acceptance criteria, rather than one average. Ask whether assay conditions stayed consistent. They do not always.
Lot-to-lot variation is normal, but unexplained swings deserve questions. Request representative certificates of analysis and details on sample size, test timing, and methods. If possible, have your team assess a sample using its own thaw workflow and compare the results with supplier data. This takes time, and it may not resolve every discrepancy. Still, a transparent supplier should explain differences without promising identical performance in every experiment.
How to Choose a Reliable Stem Cell Supplier? — Compare Post-Thaw Viability, Recovery, and Potency Data Across Lots
| Illustrative Lot ID |
Cell Type |
Passage |
Post-Thaw Viability |
Viable Cell Recovery |
Potency Assay |
Potency Result |
Sterility |
Mycoplasma |
Endotoxin |
Key Documentation |
| Example Lot A |
Human bone marrow mesenchymal stromal cells (BM-MSCs) |
Passage 4 |
89%
Trypan blue exclusion |
78%
7.8 million viable cells recovered from a 10 million viable-cell label claim |
IFN-γ-induced IDO activity |
96% of reference control |
No growth detected |
Not detected |
0.08 EU/mL |
Lot-specific certificate of analysis; thaw and assay methods documented |
| Example Lot B |
Human bone marrow mesenchymal stromal cells (BM-MSCs) |
Passage 5 |
84%
Trypan blue exclusion |
72%
7.2 million viable cells recovered from a 10 million viable-cell label claim |
IFN-γ-induced IDO activity |
88% of reference control |
No growth detected |
Not detected |
0.11 EU/mL |
Lot-specific certificate of analysis; thaw and assay methods documented |
| Example Lot C |
Human bone marrow mesenchymal stromal cells (BM-MSCs) |
Passage 4 |
92%
Trypan blue exclusion |
83%
8.3 million viable cells recovered from a 10 million viable-cell label claim |
IFN-γ-induced IDO activity |
103% of reference control |
No growth detected |
Not detected |
0.06 EU/mL |
Lot-specific certificate of analysis; thaw and assay methods documented |
Data note: All lot IDs and numerical results above are simulated examples for demonstrating a comparison format; they are not actual supplier results. Viable cell recovery is calculated as recovered viable cells divided by the labeled viable-cell count. Potency results are relative to an assay reference control. Assay methods, acceptance criteria, and relevant limits should be verified in the supplier’s lot-specific documentation; there is no universal potency cutoff for all MSC products.
